Caris Life Sciences, Inc. (CAI)
NMS – Real Time Price. Currency in USD
16.76
+0.82 (5.14%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
16.76
+0.82 (5.14%)
At close: May 12, 2026, 4:00 PM EDT
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company’s molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.
| Name | Position |
|---|---|
| Dr. David Spetzler M.B.A., M.S., Ph.D. | President |
| Dr. David Dean Halbert M.D. | Chairman, CEO & Founder |
| Dr. Milan Radovich Ph.D. | Senior VP & Chief Scientific Officer |
| Dr. Valeriy Domenyuk | Senior VP & CTO |
| Mr. Brian J. Brille J.D. | Executive Vice Chairman & Executive VP |
| Mr. J. Russel Denton | Senior VP, General Counsel & Secretary |
| Mr. Jon Mark Harmon | Senior VP & Chief Operations Officer |
| Mr. Luke Power | Senior VP, CFO & Chief Accounting Officer |
| Mr. Narendra Chokshi | Senior Vice President of Corporate Development |
| Ms. Ginger Appleberry J.D. | Senior VP, Deputy General Counsel & Chief Compliance Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | 10-Q | cai-20260331.htm |
| 2026-05-07 | 8-K | cai-20260507.htm |
| 2026-04-23 | DEFA14A | additionaldefinitiveproxys.htm |
| 2026-04-23 | DEF 14A | cai-20260423.htm |
| 2026-04-02 | 8-K | cai-20260401.htm |
| 2026-03-03 | 10-K | cai-20251231.htm |
| 2026-02-26 | 8-K | cai-20260226.htm |
| 2026-01-12 | 8-K | cai-20260112.htm |
| 2025-11-05 | 10-Q | cai-20250930.htm |
| 2025-10-30 | 8-K | cai-20251030.htm |